Dhanada Corporation Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 5, 2025, 8:15 pm

Competitors of Dhanada Corporation Ltd

All Competitor Stocks of Dhanada Corporation Ltd

Quarterly Result

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for Dhanada Corporation Ltd based on the most recent figures (Sep 2022) and their trends compared to the previous period:

• For Sales, as of Sep 2022, the value is 2.01 Cr.. The value appears to be declining and may need further review. It has decreased from 2.29 Cr. (Jun 2022) to 2.01 Cr., marking a decrease of 0.28 Cr..
• For Expenses, as of Sep 2022, the value is 1.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.13 Cr. (Jun 2022) to 1.71 Cr., marking a decrease of 0.42 Cr..
• For Operating Profit, as of Sep 2022, the value is 0.30 Cr.. The value appears strong and on an upward trend. It has increased from 0.16 Cr. (Jun 2022) to 0.30 Cr., marking an increase of 0.14 Cr..
• For OPM %, as of Sep 2022, the value is 14.93%. The value appears strong and on an upward trend. It has increased from 6.99% (Jun 2022) to 14.93%, marking an increase of 7.94%.
• For Other Income, as of Sep 2022, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Jun 2022) to 0.02 Cr., marking an increase of 0.01 Cr..
• For Interest, as of Sep 2022, the value is 1.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.30 Cr. (Jun 2022) to 1.37 Cr., marking an increase of 0.07 Cr..
• For Depreciation, as of Sep 2022, the value is 0.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Jun 2022) to 0.17 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Sep 2022, the value is -1.22 Cr.. The value appears strong and on an upward trend. It has increased from -1.29 Cr. (Jun 2022) to -1.22 Cr., marking an increase of 0.07 Cr..
• For Tax %, as of Sep 2022, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2022) which recorded 0.00%.
• For Net Profit, as of Sep 2022, the value is -1.22 Cr.. The value appears strong and on an upward trend. It has increased from -1.29 Cr. (Jun 2022) to -1.22 Cr., marking an increase of 0.07 Cr..
• For EPS in Rs, as of Sep 2022, the value is -0.22. The value appears strong and on an upward trend. It has increased from -0.23 (Jun 2022) to -0.22, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: Unknown

Growth

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:27 pm

Below is a detailed analysis of the balance sheet data for Dhanada Corporation Ltd based on the most recent figures (Sep 2022) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2022, the value is 5.59 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 5.59 Cr..
• For Reserves, as of Sep 2022, the value is -9.35 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -6.85 Cr. (Mar 2022) to -9.35 Cr., marking a decline of 2.50 Cr..
• For Borrowings, as of Sep 2022, the value is 37.15 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 34.48 Cr. (Mar 2022) to 37.15 Cr., marking an increase of 2.67 Cr..
• For Other Liabilities, as of Sep 2022, the value is 3.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.89 Cr. (Mar 2022) to 3.67 Cr., marking an increase of 0.78 Cr..
• For Total Liabilities, as of Sep 2022, the value is 37.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.11 Cr. (Mar 2022) to 37.06 Cr., marking an increase of 0.95 Cr..
• For Fixed Assets, as of Sep 2022, the value is 22.01 Cr.. The value appears to be declining and may need further review. It has decreased from 22.32 Cr. (Mar 2022) to 22.01 Cr., marking a decrease of 0.31 Cr..
• For CWIP, as of Sep 2022, the value is 1.88 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 1.88 Cr..
• For Investments, as of Sep 2022, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2022, the value is 13.17 Cr.. The value appears strong and on an upward trend. It has increased from 11.91 Cr. (Mar 2022) to 13.17 Cr., marking an increase of 1.26 Cr..
• For Total Assets, as of Sep 2022, the value is 37.06 Cr.. The value appears strong and on an upward trend. It has increased from 36.11 Cr. (Mar 2022) to 37.06 Cr., marking an increase of 0.95 Cr..

However, the Borrowings (37.15 Cr.) are higher than the Reserves (-9.35 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Dhanada Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 17, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 17, the value is -0.62. This value is below the healthy minimum of 5. It has decreased from -0.52 (Mar 16) to -0.62, marking a decrease of 0.10.
• For Diluted EPS (Rs.), as of Mar 17, the value is -0.62. This value is below the healthy minimum of 5. It has decreased from -0.52 (Mar 16) to -0.62, marking a decrease of 0.10.
• For Cash EPS (Rs.), as of Mar 17, the value is -0.26. This value is below the healthy minimum of 3. It has decreased from -0.08 (Mar 16) to -0.26, marking a decrease of 0.18.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 3.35. It has decreased from 4.05 (Mar 16) to 3.35, marking a decrease of 0.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 3.35. It has decreased from 4.05 (Mar 16) to 3.35, marking a decrease of 0.70.
• For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 1.58. It has increased from 1.53 (Mar 16) to 1.58, marking an increase of 0.05.
• For PBDIT / Share (Rs.), as of Mar 17, the value is 0.26. This value is below the healthy minimum of 2. It has decreased from 0.37 (Mar 16) to 0.26, marking a decrease of 0.11.
• For PBIT / Share (Rs.), as of Mar 17, the value is -0.11. This value is below the healthy minimum of 0. It has decreased from -0.08 (Mar 16) to -0.11, marking a decrease of 0.03.
• For PBT / Share (Rs.), as of Mar 17, the value is -0.63. This value is below the healthy minimum of 0. It has decreased from -0.53 (Mar 16) to -0.63, marking a decrease of 0.10.
• For Net Profit / Share (Rs.), as of Mar 17, the value is -0.63. This value is below the healthy minimum of 2. It has decreased from -0.53 (Mar 16) to -0.63, marking a decrease of 0.10.
• For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is -0.61. This value is below the healthy minimum of 2. It has decreased from -0.51 (Mar 16) to -0.61, marking a decrease of 0.10.
• For PBDIT Margin (%), as of Mar 17, the value is 16.70. This value is within the healthy range. It has decreased from 24.53 (Mar 16) to 16.70, marking a decrease of 7.83.
• For PBIT Margin (%), as of Mar 17, the value is -7.19. This value is below the healthy minimum of 10. It has decreased from -5.32 (Mar 16) to -7.19, marking a decrease of 1.87.
• For PBT Margin (%), as of Mar 17, the value is -40.48. This value is below the healthy minimum of 10. It has decreased from -35.30 (Mar 16) to -40.48, marking a decrease of 5.18.
• For Net Profit Margin (%), as of Mar 17, the value is -40.45. This value is below the healthy minimum of 5. It has decreased from -35.25 (Mar 16) to -40.45, marking a decrease of 5.20.
• For NP After MI And SOA Margin (%), as of Mar 17, the value is -39.10. This value is below the healthy minimum of 8. It has decreased from -33.90 (Mar 16) to -39.10, marking a decrease of 5.20.
• For Return on Networth / Equity (%), as of Mar 17, the value is -18.42. This value is below the healthy minimum of 15. It has decreased from -12.78 (Mar 16) to -18.42, marking a decrease of 5.64.
• For Return on Capital Employeed (%), as of Mar 17, the value is -3.03. This value is below the healthy minimum of 10. It has decreased from -1.72 (Mar 16) to -3.03, marking a decrease of 1.31.
• For Return On Assets (%), as of Mar 17, the value is -7.73. This value is below the healthy minimum of 5. It has decreased from -6.30 (Mar 16) to -7.73, marking a decrease of 1.43.
• For Long Term Debt / Equity (X), as of Mar 17, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 16) to 0.08, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 17, the value is 1.18. This value exceeds the healthy maximum of 1. It has increased from 0.87 (Mar 16) to 1.18, marking an increase of 0.31.
• For Asset Turnover Ratio (%), as of Mar 17, the value is 0.21. It has increased from 0.19 (Mar 16) to 0.21, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 17, the value is 0.16. This value is below the healthy minimum of 1.5. It has increased from 0.13 (Mar 16) to 0.16, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 17, the value is 0.15. This value is below the healthy minimum of 1. It has increased from 0.12 (Mar 16) to 0.15, marking an increase of 0.03.
• For Interest Coverage Ratio (X), as of Mar 17, the value is 0.50. This value is below the healthy minimum of 3. It has decreased from 0.81 (Mar 16) to 0.50, marking a decrease of 0.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is -0.21. This value is below the healthy minimum of 3. It has decreased from -0.17 (Mar 16) to -0.21, marking a decrease of 0.04.
• For Enterprise Value (Cr.), as of Mar 17, the value is 45.75. It has decreased from 53.35 (Mar 16) to 45.75, marking a decrease of 7.60.
• For EV / Net Operating Revenue (X), as of Mar 17, the value is 5.18. This value exceeds the healthy maximum of 3. It has decreased from 6.25 (Mar 16) to 5.18, marking a decrease of 1.07.
• For EV / EBITDA (X), as of Mar 17, the value is 31.02. This value exceeds the healthy maximum of 15. It has increased from 25.48 (Mar 16) to 31.02, marking an increase of 5.54.
• For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 2.86. This value is within the healthy range. It has decreased from 4.00 (Mar 16) to 2.86, marking a decrease of 1.14.
• For Price / BV (X), as of Mar 17, the value is 1.35. This value is within the healthy range. It has decreased from 1.51 (Mar 16) to 1.35, marking a decrease of 0.16.
• For Price / Net Operating Revenue (X), as of Mar 17, the value is 2.86. This value is within the healthy range. It has decreased from 4.00 (Mar 16) to 2.86, marking a decrease of 1.14.
• For EarningsYield, as of Mar 17, the value is -0.13. This value is below the healthy minimum of 5. It has decreased from -0.08 (Mar 16) to -0.13, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness